{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:25:51Z","timestamp":1793805951153,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urolonc.2026.06.016","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:14:47Z","timestamp":1783768487000},"page":"475-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry"],"prefix":"10.1016","volume":"44","author":[{"given":"Timon","family":"Winistoerfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"R\u00f6thlisberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Phat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Engeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e4to","family":"Strebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Schneidewind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9844-1799","authenticated-orcid":false,"given":"Nicola","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.06.016_bib0001","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0002","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S1470-2045(21)00493-9","article-title":"Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study","volume":"22","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0003","article-title":"Impact of the COVID-19 pandemic on prostate cancer diagnosis, staging, and treatment: a population-based study in Northern Italy","volume":"13","author":"Mangone","year":"2024","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0004","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamaoncol.2022.0467","article-title":"Association of the COVID-19 pandemic with rates of prostate cancer biopsies and diagnoses in black vs white US veterans","volume":"8","author":"Klaassen","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bju.16305","article-title":"During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England","volume":"133","author":"Lemanska","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0006","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/iju.70085","article-title":"Impact of the COVID-19 pandemic on prostate cancer: perturbations in screening and diagnostic patterns","volume":"32","author":"Noro","year":"2025","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0007","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0008","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00345-020-03402-w","article-title":"Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic","volume":"39","author":"Diamand","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.11.010","article-title":"Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: can surgery be postponed safely?","volume":"35","author":"Fossati","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/JU.0000000000001089","article-title":"Delayed radical prostatectomy is not associated with adverse oncologic outcomes: implications for men experiencing surgical delay due to the COVID-19 pandemic","volume":"204","author":"Ginsburg","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0011","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bju.14659","article-title":"Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate-risk to very-high-risk clinically localised prostate cancer","volume":"124","author":"Gupta","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0012","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00345-018-2251-5","article-title":"Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter?","volume":"36","author":"Morini","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/bju.14671","article-title":"Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?","volume":"124","author":"Reichard","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/pros.22582","article-title":"Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database","volume":"73","author":"Abern","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1158\/1055-9965.EPI-18-0812","article-title":"Optimizing time to treatment to achieve durable biochemical disease control after surgery in prostate cancer: a multi-institutional cohort study","volume":"28","author":"Awasthi","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108398","article-title":"Is it safe to defer prostate cancer treatment? Assessing the impact of surgical delay on the risk of pathological upstaging after robot-assisted radical prostatectomy","volume":"50","author":"Di Maida","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.purol.2018.05.003","article-title":"[Does the delay from prostate biopsy to radical prostatectomy influence the risk of biochemical recurrence?]","volume":"28","author":"Meunier","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0018","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1590\/s1677-5538.ibju.2018.0196","article-title":"Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy","volume":"45","author":"Westerman","year":"2019","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-017-2105-6","article-title":"Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort","volume":"36","author":"Zanaty","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0022","doi-asserted-by":"crossref","DOI":"10.1007\/s11701-026-03350-4","article-title":"Teaching in radical prostatectomy is safe: a multicenter prospective registry analysis","volume":"20","author":"Giudici","year":"2026","journal-title":"J Robot Surg"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0023","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00345-025-06173-4","article-title":"How safe is teaching radical cystectomy?: results from the prospective Swiss society of urology database","volume":"44","author":"Scherrer","year":"2026","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0024","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/JU.0000000000004484","article-title":"The absolute volume of gleason pattern 4 on radical prostatectomy is more strongly associated with advanced stage and biochemical recurrence than Gleason grade groups","volume":"213","author":"Scuderi","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/JU.0000000000001601","article-title":"Systematic review of time to definitive treatment for intermediate risk and high risk prostate cancer: are delays associated with worse outcomes?","volume":"205","author":"Nguyen","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0026","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s00345-021-03703-8","article-title":"Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review","volume":"39","author":"Laukhtina","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133274","article-title":"Effects of delayed radical prostatectomy and active surveillance on localised prostate cancer: a systematic review and meta-analysis","volume":"13","author":"Chan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.urolonc.2026.06.016_bib0028","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0029","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0030","doi-asserted-by":"crossref","first-page":"387.e317","DOI":"10.1016\/j.urolonc.2023.04.019","article-title":"Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer","volume":"41","author":"Pellegrino","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2026.06.016_bib0031","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:29:53Z","timestamp":1793802593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1078143926005740"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopsy-to-treatment delay in prostate cancer: Postpandemic impact in a swiss national, multicenter, prospective registry","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}